AbbVie (NYSE: ABBV) recently announced that it has acquired a West Pharmaceutical Services (NYSE: WST) plant in Tempe, Arizona. North Chicago, Illinois–based AbbVie said on Jan. 12 that it plans to hire roughly 200 employees at the site and invest more than $175 million to acquire, modernize, and fully integrate the facility into its manufacturing…
Leading Pharmacy Automation Companies Transforming Health Care
The rising demand for accuracy, efficiency and real-time visibility has made pharmacy automation an integral part of both retail and hospital pharmacy operations. Automation technologies help reduce human errors, streamline workflows and support safer medication management across the care continuum. Medication errors are one of the most common and preventable sources of patient harm. The…
Apiject to open new injectable drug manufacturing facility in North Carolina
Apiject announced today that it signed a lease on a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina. The injection delivery system developer plans for the new facility to house two advanced blow-fill-seal (BFS) production lines and serve as an outsourcing facility focused on producing essential generic injectable medicines currently on the FDA’s drug shortage…
BD to invest $110M to support prefilled syringe production, pharma supply chain
BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, Nebraska. Franklin Lakes, New Jersey–based BD aims to expand prefillable syringe production to accelerate biologic and GLP-1 drug delivery and support pharmaceutical reshoring in the U.S. The investment brings the company’s Neopak glass prefillable syringe production to…
Johnson & Johnson announces new North Carolina pharma plant
Johnson & Johnson (NYSE:JNJ) is expanding in Wilson County, North Carolina, with a new multibillion-dollar pharmaceutical facility. The company expects to create up to 500 new jobs in the community through the project in Wilson. It marks the second time in 14 months that J&J has announced a significant project in the area after a…
Myths about conveyors and measures to make data-driven purchasing decisions
Conveyors provide healthcare packaging operations with a critical function – seamlessly moving product from one station to the next. A function seemingly so simple, it’s at risk of being overlooked for proper analysis before implementation. But conveyors build the foundation of every successful packaging operation, and investing the time to analyze the varying options and…
Samsung Biologics acquires GSK manufacturing site
Samsung Biologics announced today that it agreed to acquire 100% of Human Genome Sciences from GSK. The acquisition secures Samsung Biologics’ first U.S.-based manufacturing site, located in Rockville, Maryland. It helps to expand the company’s global footprint and commitment to the U.S. market following its transition to become a pure-play CDMO. GSK’s Rockville facility encompasses…
Chitose, Fujifilm Biosciences partner on biopharma manufacturing
Chitose announced today that it entered into a new partnership with Fujifilm Biosciences to advance biopharmaceutical production. According to a news release, the alliance aims to leverage the strengths of both companies to produce higher-quality biopharmaceutical products. Chitose brings expertise in cell line development, using the established CHO-MK cells. The company said this aligns with…
Novartis breaks ground on North Carolina facility
Novartis announced today that it broke ground on its more than 700,000-square-foot flagship manufacturing hub in North Carolina. The company said it is rapidly moving to construct its recently announced $771 million investment in the state. Its project features a new facility in Morrisville and a new site in Durham, encompassing two new facilities. The…
Eli Lilly to build new $6B API manufacturing facility in Alabama
Eli Lilly (NYSE:LLY) announced that it plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama. The next-generation synthetic medicine active pharmaceutical ingredient (API) facility marks the third of four new U.S. sites. It follows the new facilities announced in Virginia and Texas. Eli Lilly plans for the plant to produce small-molecule…









